EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed cby the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F22%3A00083811" target="_blank" >RIV/00023001:_____/22:00083811 - isvavai.cz</a>
Result on the web
<a href="https://academic.oup.com/europace/article/24/12/1981/6661340?login=true" target="_blank" >https://academic.oup.com/europace/article/24/12/1981/6661340?login=true</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1093/europace/euac125" target="_blank" >10.1093/europace/euac125</a>
Alternative languages
Result language
angličtina
Original language name
EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed cby the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society
Original language description
Mitral valve prolapse (MVP) is the most common valvular heart disease, affecting about 2–3% of the general population and is wellcharacterized by echocardiography. While the outcome in MVP ismostly benign in the absence of mitral regurgitation (MR) and its left ventricular (LV) consequences, a small yet poorly defined subset ofindividuals remain at higher risk of malignant ventricular arrhythmias(VAs) and sudden cardiac death (SCD). This link between MVP andSCD is reported with an annual incidence <1% in unselectedindividuals with MVP. However, at autopsy, the prevalence ofMVP among young patients with sudden arrhythmic death is reported between 4% to up to 7%. Due to the low event-rateand the lack of very large cohorts, assessing the precise incidenceof SCD in MVP in general and in specific subsets of patients remainschallenging.Mitral annular disjunction (MAD, discussed in detail in section 4) isoften observed concomitantly with MVP. MAD results in anabnormal motion of the mitral annulus, termed curling. It isassociated with increased risk of arrhythmias and is thereforeand integral component of the arrhythmic MVP (AMVP)complex.Over the last decade, a multidisciplinary approach has been employed to identify specific MVP subsets with high arrhythmic riskby careful examination of electrocardiograms (ECG), DopplerEechocardiography, cardiac magnetic resonance (CMR) imaging, cardiac computed tomography imaging (CT) and confirmed by autopsyfindings.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Europace
ISSN
1099-5129
e-ISSN
1532-2092
Volume of the periodical
24
Issue of the periodical within the volume
12
Country of publishing house
GB - UNITED KINGDOM
Number of pages
23
Pages from-to
1981-2003
UT code for WoS article
000838798800001
EID of the result in the Scopus database
2-s2.0-85142034945